Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial

Overview of attention for article published in Trials, October 2017

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 77 Mendeley

So far, Altmetric has seen 1 X post from an account with 1,384 followers.

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-n… https://t.co/gGjFgvN171

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.